ArticleCureus2022

Long-Term Survival of a Patient With Peritoneal Carcinomatosis From Pancreatic Cancer Maintained by Nanoliposomal Irinotecan as Third-Line Chemotherapy.

Keiji Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.